$4.36
+0 (+0%)
At Close: Mar 06, 2026
Editas Medicine (EDIT) to Release Earnings on Thursday
06:40am, Wednesday, 05'th Aug 2020
Editas Medicine (NASDAQ:EDIT) will issue its quarterly earnings data after the market closes on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.80) per share for the quar
Charting a solid August start: S&P 500, Nasdaq stage latest summer breakouts
04:38pm, Tuesday, 04'th Aug 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish amid a solid August start, writes Michael Ashbaugh.
Regeneron’s Covid-19 Antibody Looks Promising in Animal Test
03:24pm, Tuesday, 04'th Aug 2020
Company scientists posted a paper about a trial of the drug in monkeys and hamsters.
Regeneron says antibody cocktail prevents and treats coronavirus in animals
09:23am, Tuesday, 04'th Aug 2020
Regeneron Pharmaceuticals said the Covid-19 antibody-drug combination it is developing both prevented and treated the disease in rhesus macaques and hamsters, adding to hope that it might work for peo
World Retinal Biologics Market: Growth, Trends and Forecasts (2020-2025) - ResearchAndMarkets.com
12:00am, Tuesday, 04'th Aug 2020
The
Buy Merck for Its Unappreciated Pipeline, Says Goldman
02:47pm, Monday, 03'rd Aug 2020
Terrence Flynn upgraded Merck stock to Buy from Hold, saying the drug giant has plenty more of value even after cancer treatment Keytruda expires toward the decade’s end.
Eli Lilly Stock Is Rising as the Company Tests a Covid-19 Antibody Drug In Nursing Homes
01:16pm, Monday, 03'rd Aug 2020
The company said it had begun a Phase 3 trial of up to 2,400 residents and staff who live or work at a nursing home that has recently had a case of Covid-19.
Eli Lilly starts late-stage study of coronavirus drug in nursing homes
10:52am, Monday, 03'rd Aug 2020
U.S. drugmaker Eli Lilly said on Monday it is beginning a late-stage trial to study whether one of its experimental Covid-19 antibody treatments can prevent the virus' spread in residents and staff in
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company has submitted a clinical trial a
Disney, T-Mobile, CVS, Activision Blizzard, and Other Stocks for Investors to Watch This Week
07:00pm, Sunday, 02'nd Aug 2020
Second-quarter earnings season continues with results from Disney, T-Mobile, Fox, ViacomCBS, and Clorox. Video-game makers Take-Two and Activision Blizzard also report. Plus, July jobs data.
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Pitcairn Co. Has $419,000 Stock Position in Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
08:56am, Saturday, 01'st Aug 2020
Pitcairn Co. grew its holdings in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by 4.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
Allegiant Flies Above the Pack With Its Budget-Meets-Leisure Formula
12:37am, Saturday, 01'st Aug 2020
In a year in which airlines have gotten hammered by the pandemic, a carrier with ultralow costs and flexible scheduling takes the lead. Not that the flight may not get a little rough.
The jobs report and congressional politics may matter more for markets than earnings in the week ahead
09:06pm, Friday, 31'st Jul 2020
The market could lose some exuberance as the calendar turns to August, and investors await Friday's July employment report.
Worsening eye sight doesn't stop for Covid, neither did we
05:05am, Friday, 31'st Jul 2020
New campaign urges Irish public to keep eye care appointments and be vigilant for signs of age-related macular degeneration
Sign In
Buy ADVM